The conversation discusses hair regrowth progress using Minoxidil, finasteride, and RU58841. It highlights the transformation of vellus hairs into terminal hairs in a Norwood 6 frontal area.
The conversation discusses hair loss treatments, including topical and oral minoxidil, finasteride, RU58841, and microneedling. Users suggest adding oral dutasteride or finasteride for more effective results.
The conversation is about the anticipation of results for a hair loss treatment study, specifically for GT20029, with expectations for the results to be released in the first quarter of 2024. No specific treatments were discussed.
A user experienced significant hair regrowth after 4 months using topical finasteride and minoxidil, along with dermastamping and biotin supplements, without side effects. They are not considering a hair transplant due to the success of this regimen.
The user reported gradual hair regrowth after 4 months using oral finasteride, topical minoxidil, dermastamping, and vitamins C and D3. They noted the use of a 1.25mm dermastamp and discussed sourcing finasteride in Canada.
The conversation discusses a hair loss treatment regimen involving minoxidil, finasteride, RU58841, JXL069, and nizoral shampoo. The user reports seeing new black dots in areas where hair hasn't grown in years, suggesting potential regrowth.
The conversation discusses experimenting with microneedling for hair loss, with OP considering using a 3mm derma-stamp. Other users advise against going beyond 1.5mm to avoid damage.
A 26-year-old man with diffuse alopecia is using electric scalp massage, dermastamp, and multivitamins for treatment but is intolerant to finasteride. A dermatologist recommended PRP and mesotherapy with exosomes and dutasteride.
A user has been using finasteride and minoxidil for six months and is concerned about hair loss. Replies suggest continuing the treatment for at least a year, as initial shedding can indicate the treatment is working.
The user used minoxidil 5% and finasteride 0.1% for six months, along with a dermaroller and Nizoral shampoo, experiencing only dry scalp as a side effect. They are pleased with the results.
The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.
A 30-year-old male shares his 6-month progress using 1mg oral finasteride and 2.5mg oral minoxidil, noting increased hair thickness and regrowth. He also mentions using supplements like biotin and cod liver oil and discusses the convenience of combined pills.
A new topical treatment, PP405, shows promising results for hair regrowth, potentially outperforming existing treatments like finasteride and minoxidil. However, it may still need to be combined with DHT blockers for optimal results, and its long-term effectiveness remains uncertain.
Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.
The user shared progress on hair regrowth using 5mg oral Minoxidil and 0.5mg oral dutasteride daily, noting no side effects except for hairier eyebrows and hands. Users suggested considering a hair transplant, adding topical treatments, and continuing the regimen for further improvement.
The conversation discusses the synthesis and potential use of JXL069 and PP405 for hair loss treatment, with skepticism about their effectiveness and concerns about safety. Users mention that JXL069 has shown no results in hair growth, and there is confusion about its identity and effectiveness compared to PP405.
The post discusses hair loss treatment progress using oral finasteride 1mg daily for 6 months, with improvements in the hairline but not the crown. The user avoids minoxidil due to side effects and plans to try PP405 for better density.
The conversation discusses the potential effectiveness of a Sult1a1 enzyme booster in enhancing the results of minoxidil for hair loss. Users express interest in the booster, hoping it will improve the effectiveness of oral minoxidil, especially for those who struggle with topical application.
A user discusses a hair loss treatment combining minoxidil and tretinoin, noting it may enhance absorption. Some users express interest and share positive experiences, while others question its effectiveness without medical evidence.
A 26-year-old man shared his 6-month hair regrowth progress using 0.25% topical finasteride, 5% topical minoxidil, Trichosol, and weekly derma stamping. He plans to start using a lotion with dutasteride and azelaic acid.
The conversation discusses the effectiveness of Vichy Dercos Aminexil Clinical R.E.G.E.N. Booster for hair shedding and thinning. The main ingredient, Aminexil, is compared to Minoxidil, and the user seeks real experiences to determine its efficacy.
FLEAVA is accused of scamming customers by enrolling them in unwanted monthly subscriptions for Advanced Copper Peptide without consent. Many users struggled to get refunds and reported ongoing charges despite cancellation requests.
The user started using Agerin cream on their scalp and noticed some hair growth, despite not applying it consistently. They also use Minoxidil, RU58841, dutasteride, and finasteride, and have seborrheic dermatitis.
Clascoterone (Breezula) is anticipated for release in the coming years but is considered too weak for aggressive androgenetic alopecia (AGA). Current treatments like minoxidil, finasteride, and dutasteride are preferred, with some users obtaining clascoterone from the gray market.
A 30-year-old male is seeing progress in hair growth after 5 months of using a chewable blend of finasteride, minoxidil, and supplements, along with derma rolling. He reports a slight decrease in libido but is generally pleased with the results and is considering adding low-level laser therapy (LLLT) to his regimen.
Alfatradiol (0.025%) is an effective and safe treatment for androgenetic alopecia in both men and women, increasing anagen hair rates with minimal side effects. Users discuss its cost-effectiveness and ease of use compared to other treatments like finasteride and RU58841, with some combining it with stemoxydine and Minoxidil.
The conversation discusses the use of AlphaInfuse, a micro-infusion system with Panax ginseng and Eclipta prostrata extracts, for hair growth and its comparison to Minoxidil. The original poster seeks personal experiences and evidence of its effectiveness.
Breezula (cb-03-01) and kx-826 are discussed as hair loss treatments. Kx-826 is available on Kintor's website, while Breezula is available on the grey market.
A user shared their 6-week update on using 0.5mg dutasteride daily, 2.5mg oral minoxidil, and Nizoral for hair loss, noting noticeable regrowth but experiencing side effects like lower sex drive and brain fog. The conversation includes suggestions for additional treatments and discussions about hair transplant costs.